Note: Pathogenes's revenues are gauged from an analysis of company filings.
Pathogenes's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Pathogenes Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Pathogenes is developing and marketing.
Pathogenes doesn't have any recent trademark applications, indicating Pathogenes is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
NEUROQUEL Pharmaceutical preparations for the treatment of inflammataory encephalitis in horses
OROGIN Therapeutic pharmaceutical for the treatment of infections due to Sarcocystis neurona equine protozoal myeloencephalitis
LEVAMISOLVE Pharmaceutical preparations for the treatment of inflammatory encephalitis in horses
Determine whether Pathogenes grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Pathogenes is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Pathogenes vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Pathogenes, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Pathogenes.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Pathogenes and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.